Skip to main content
Premium Trial:

Request an Annual Quote

Out with the Old, In with the New

Scoop reports on a meeting planned for this summer in Altenberg, Austria at which "16 biologists and philosophers of rock star stature" will assemble to talk about the need to update our theory of evolution. (As opponents say, it's just a theory, right?)

The attendees are people who "recognize that the theory of evolution which most practicing biologists accept and which is taught in classrooms today, is inadequate in explaining our existence," according to the article. "The theory Charles Darwin gave us, which was dusted off and repackaged 70 years ago, seems about to be reborn as the 'Extended Evolutionary Synthesis.'"

 

The Scan

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.